使用腹部推力与在狗中成功诱导吐的比率提高有关
Journal of the American Veterinary Medical Association
|April 12, 2024
概括
腹部推力增加了诱导吐的成功率,在IV阿波莫尔芬给药后在狗中引起吐. 然而,这种技术并没有加速吐的狗的吐.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 毒理学 毒理学 毒理学
- 紧急医疗 紧急医疗
背景情况:
- 诱导吐是兽医毒理学中常见的一种程序.
- 阿波莫尔芬经常用于静脉诱导狗的吐.
- 对阿波莫尔芬的辅助体力运动的有效性尚未得到充分证实.
研究的目的:
- 评估腹部推进作为静脉输入阿波莫尔芬的辅助对吐诱导成功和发病速度在狗中的影响.
- 为了确定物理操纵是否增强了阿波莫芬诱导吐的有效性.
主要方法:
- 一项前性随机研究涉及31只需要诱导吐的客户拥有的狗.
- 狗接受了静脉注射的阿波莫尔芬,其中一组接受了腹部推力,对照组没有接受身体干预.
- 收集的数据包括信号,摄入和呈现时间,阿波莫尔芬剂量和吐时间.
主要成果:
- 在接受腹部推力的狗中,成功吐发生在100%的狗中,而对照组中为76.5% (P = .02).
- 在吐的狗中,吐的中位时间在两组之间是相似的 (90.5秒与推力相比106秒没有;P = .29).
结论:
- 在狗中,腹部推力在与静脉输入阿波莫尔芬相结合时,显著增加了成功诱导吐的可能性.
- 这种物理干预似乎不会加速成功吐的狗的吐.
- 腹部推力可能是有益的辅助措施诱导吐在狗,只要没有禁忌存在.
相关概念视频
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
198
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
198
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
160
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
160